Maternal generalized anxiety disorder during pregnancy and fetal brain development: A comparative study on cord blood brain-derived neurotrophic factor levels

Journal of Psychosomatic Research

Volumn 75, Issue 4, 2013, Pages 346-350

  Uguz, Faruk ^a   Sonmez, Erdem Onder ^a   Sahingoz, Mine ^a   Gokmen, Zeynel ^b   Basaran, Mustafa ^c   Gezginc, Kazim ^a   Sonmez, Gulsum ^b   Kaya, Nazmiye ^a   Erdem, Sami Sait ^b   Cicekler, Humeyra ^a   Tasyurek, Erkan ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b Konya Research and Training Hospital ^*  (Turkey)

^c Konya Research and Training Hospital   (Turkey)

Author keywords

Anxiety; Brain derived neurotrophic factor; Pregnancy

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ABORTION; ADULT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BRAIN DEVELOPMENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DELIVERY; DSM-IV; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EPIDURAL ANESTHESIA; FEMALE; FETUS DEVELOPMENT; GENERAL ANESTHESIA; GENERALIZED ANXIETY DISORDER; GESTATIONAL AGE; HUMAN; INCOME; MATERNAL DISEASE; MEDICAL HISTORY; NEWBORN; PREGNANCY; PRIMIPARA; UMBILICAL CORD BLOOD;

ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; PREGNANCY;

ADULT; ANXIETY DISORDERS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN;

EID: 84885373929     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.04.010     Document Type: Article

References (43)

1. Felice E, Saliba J, Grech V, Cox J, Calleja N Antenatal psychiatric morbidity in Maltese women. Gen Hosp Psychiatry 2007, 29:501-505.
2. Borri C, Mauri M, Oppo A, Banti S, Rambelli C, Ramacciotti D, et al. Axis I psychopathology and functional impairment at the third month of pregnancy: results from the Perinatal Depression-Research and Screening Unit (PND-ReScU) Study. J Clin Psychiatry 2008, 69:1617-1624.
3. Andersson L, Sundström-Poromaa I, Wulff M, Åström M, Bixo M Depression and anxiety disorder during pregnancy and six months postpartum: a follow-up study. Acta Obstet Gynecol 2006, 85:937-944.
4. Uguz F, Gezginc K, Kayhan F, Sari S, Buyukoz D Is pregnancy associated with mood and anxiety disorder? A cross-sectional study. Gen Hosp Psychiatry 2010, 32:213-215.
5. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007, 164:1206-1213.
6. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010, 67:1012-1024.
7. Lewis AJ, Galbally M, Opie G, Buist A Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry 2010, 44:482-487.
8. Davalos DB, Yadon CA, Tregellas HC Untreated prenatal maternal depression and the potential risks of offspring: a review. Arch Womens Ment Health 2012, 15:1-14.
9. Adewuya AO, Ola BA, Aloba OO, Mapayi BM Anxiety disorders among Nigerian women in late pregnancy: a controlled study. Arch Womens Ment Health 2006, 9:325-328.
10. Kitamura T, Yoshida K, Okano T, Kinoshita K, Hayashi M, Toyoda N, et al. Multicentre prospective study of perinatal depression in Japan: incidence and correlates of antenatal and postnatal depression. Arch Womens Mental Health 2006, 9:121-130.
11. Uguz F, Gezginc K, Yazici F Are major depression and generalized anxiety disorder associated with intrauterine growth restriction in pregnant women? A case-control study. Gen Hosp Psychiatry 2011, 33:640.e7-640.e9.
12. Sjöström K, Valentin L, Thelin T, Maršal K Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 1997, 74:149-155.
13. Alder J, Fink N, Bitzer J, Hösli I, Holzgreve W Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007, 20:189-209.
14. Suri D, Vaidya VA Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neuroscience 2013, 239:196-213.
15. Bernd P The role of neurotrophins during early development. Gene Expr 2008, 14:241-250.
16. Gorgulu Y, Caliyurt O Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res Bull 2009, 80:158-162.
17. Neeley EW, Berger R, Koenig JI, Leonard S Prenatal stress differentially alters brain-derived neurotrophic factor expression and signaling across rat strains. Neuroscience 2011, 187:24-35.
18. Gray JD, Milner TA, Mcewen BS Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience 2013, 239:214-227.
19. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1256-1260.
20. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
21. Fossati P, Radtchenko A, Boyer P Neuroplasticity: from MRI to depressive symptoms. Eur Neuropsychopharmacol 2004, 14:S503-S510.
22. Masi G, Brovedani P The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 2011, 25:913-931.
23. Rizos EN, Papathanasiou M, Michalopoulou PG, Mazioti A, Douzenis A, Kastania A, et al. Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophr Res 2011, 129:201-104.
24. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 2011, 16:960-972.
25. Fontenelle LF, Barbosa IG, Luna JV, Rocha NP, Miranda AS, Teixeira AL Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res 2012, 199:199-200.
26. Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: a case-control study. J Affect Disord 2010, 122:174-178.
27. Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, et al. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:658-663.
28. Kodomari I, Wada E, Nakamura S, Wada K Maternal supply of BDNF to mouse fetal brain through the placenta. Neurochem Int 2009, 54:95-98.
29. Ohmiya M, Shudai T, Nitta A, Nomoto H, Furukawa Y, Furukawa S Brain-derived neurotrophic factor alters cell migration of particular progenitors in the developing mouse cerebral cortex. Neurosci Lett 2002, 317:21-24.
30. Van den Hove DL, Steinbusch HW, Scheepens A, Van de Berg WD, Kooiman LA, Boosten BJ, et al. Prenatal stress and neonatal rat brain development. Neuroscience 2006, 137:145-147.
31. Talge NM, Neal C, Glover V The Early Stress, Translational Research and Prevention Science Network: fetal and neonatal experience on child and adolescent mental health. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry 2007, 48:245-261.
32. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
33. First MB, Spitzer RL, Gibbon M, Williams JBW Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV) 1997, American Psychiatric Press, Washington D.C.
34. Beck AT, Epstein N, Brown G, Steer RA An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
35. Karege F, Scwald M, Cisse M Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002, 328:261-264.
36. Chouthai NS, Sampers J, Desai N, Smith GM Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions. Pediatr Res 2003, 53:965-969.
37. Fukumitsu H, Frukawa Y, Tsusaka M, Kinukawa H, Nitta A, Nomoto H, et al. Simultaneous expression of brain-derived neurotrophic factor and neurotrophin-3 in Cajal-Retzius, subplate and ventricular progenitor cells during early development stages of the rat cerebral cortex. Neuroscience 1998, 84:115-127.
38. Lommatzsch M, Hornych K, Zingler C, Schuff-Werner P, Höppner J, Virchow JC Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology 2006, 31:388-394.
39. Diego MA, Jones NA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, et al. Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom Med 2006, 68:747-753.
40. Glover V, Bergman K, Sarkar P, O'Connor TG Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety. Psychoneuroendocrinology 2009, 34:430-435.
41. Hüppi PS, Warfield S, Kikinis R, Barnes PD, Zientara GP, Jolesz FA, et al. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 1998, 43:224-235.
42. Cui QL, D'Abate L, Fang J, Leong SY, Ludwin S, Kennedy TE, et al. Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate. Stem Cells Dev 2012, 21:1831-1837.
43. Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals 2010, 18:186-202.